Viewing Study NCT06134232


Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2025-12-28 @ 11:48 PM
Study NCT ID: NCT06134232
Status: RECRUITING
Last Update Posted: 2025-08-27
First Post: 2023-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Sponsor: Dendreon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module